Answers are grounded in this paper and cite their sources.
Biological evaluation demonstrates hydrazone derivatives improve acetylcholinesterase modulation in Alzheimer’s disease, indicating potential therapeutic effects.
This study delivers structurally refined dihydrothiazolyl hydrazone hybrids, leveraging coordinated synthetic design, SAR guidance, and molecular modeling to achieve precise dual-site modulation of acetylcholinesterase enzyme for the treatment of Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: